Embryonic Stem Cells News and Research

RSS

Stem Cell Sciences granted UK patent for new growth medium for authentic embryonic stem cells

Stem Cell Sciences plc today announced that the UK Patent Office has granted it a patent covering the Company's new range of stem cell culture media. The new Culticell iSTEM range uses the inhibitor based technology discovered by Professor Austin Smith and recently published in Nature (vol. 453, pp.519-523).

8 Jul 2008

New method to evaluate variations identified in breast cancer susceptibility genes

Using mouse embryonic stem cells, researchers at the National Cancer Institute (NCI), part of the National Institutes of Health, have developed a new method to evaluate which mutations, or changes, in a gene known to increase breast cancer susceptibility, may lead to cancer. The new test, called a functional assay, is more comprehensive and reliable than most current methods.

7 Jul 2008

Scientists shed new light into early mechanisms governing cardiovascular specification

The mature heart is composed by different cell types, including contractile cardiac cells, vascular cells, smooth muscle cells as well as pacemaker cells.

3 Jul 2008

Mouse embryonic stem cells used to build heart parts

Researchers have shown that they can put mouse embryonic stem cells to work building the heart, potentially moving medical science a significant step closer to a new generation of heart disease treatments that use human stem cells.

2 Jul 2008

New technique produces genetically identical stem cells

Adult cells of mice created from genetically reprogrammed cells-so-called induced pluripotent stem (IPS) stem cells-can be triggered via drug to enter an embryonic-stem-cell-like state, without the need for further genetic alteration.

1 Jul 2008

Stem cell research from an ethical point of view

New Springer book debates the moral status of the human embryo with special regard to stem cell research and therapy.

1 Jul 2008

Neural stem cell development may be linked to Autism

In a breakthrough scientific study published today in the Proceedings of the National Academy of Sciences, scientists at the Burnham Institute for Medical Research have shown that neural stem cell development may be linked to Autism.

30 Jun 2008

Protein Ronin shown to be an alternate control for embryonic stem cells

Like the masterless samurai for whom it is named, the protein Ronin chooses an independent path, maintaining embryonic stem cells in their undifferentiated state and playing essential roles in genesis of embryos and their development, said Baylor College of Medicine researchers who reported on this novel cellular regulator in the current issue of the journal Cell.

27 Jun 2008

Scholarships for stem-cell research

The NSW Government has named two new scholarships for stem-cell research in honour of Paul Brock, an adjunct professor at the University of Sydney and a leading figure in Australia's education community.

25 Jun 2008

Nerve cells derived from embryonic stem cells and transplanted into mice may lead to improved brain therapies

Scientists at the Burnham Institute for Medical Research have, for the first time, genetically programmed embryonic stem (ES) cells to become nerve cells when transplanted into the brain, according to a study published today in The Journal of Neuroscience.

24 Jun 2008

Adult stem cells improve healing of broken bones

Adult stem cells improve healing of broken bones and could eventually serve as a new treatment for the 10 to 20 percent of fractures that fail to heal, according to a new study. The results were presented Monday, June 16, at The Endocrine Society's 90th Annual Meeting in San Francisco, by Froilan Granero-Molto, PhD, research associate of the University of North Carolina.

16 Jun 2008

VistaGen Therapeutics announces new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells

VistaGen Therapeutics, Inc., a biotechnology company using leading-edge embryonic stem cell (ES Cell) technologies for predictive toxicology and drug discovery, has announced new broad composition of matter patent protection for its ES Cell-derived pluripotent precursor cells. VistaGen has exclusive rights for commercial use in its ES Cell-based tools platform for drug discovery and development.

16 Jun 2008

Nose stem cells used to treat Parkinson's

Scientists in Queensland, Australia have made a major breakthrough in research into Parkinson's disease.

9 Jun 2008

Australia to enter the race to clone human embryo cells for stem-cell research

Melbourne's Monash University may be granted the first licence in Australia to clone human embryo cells for stem-cell research.

9 Jun 2008

Public funding impacts progress of human embryonic stem cell research

Bolstered by supportive policies and public research dollars, the United Kingdom, Israel, China, Singapore and Australia are producing unusually large shares of human embryonic stem cell research, according to a report from the Georgia Institute of Technology in the June 2008 issue Cell Stem Cell.

5 Jun 2008

Enzyme plays key role in cell fate

The road to death or differentiation follows a similar course in embryonic stem cells, said researchers at Baylor College of Medicine in Houston in a report that appears online today in the journal Cell Stem Cell.

5 Jun 2008

Bone repair using patient's stem cells comes closer

Hitherto it has been difficult to induce adult human stem cells to produce bone, e.g. in order to repair bone tissue. Researchers at the University of Twente have shown that if the enzyme PKA is previously activated in the stem cells in the lab, following implantation this results in substantial bone formation.

26 May 2008

How embryonic stem cells develop into tissue-specific cells demonstrated by researchers

While it has long been known that embryonic stem cells have the ability to develop into any kind of tissue-specific cells, the exact mechanism as to how this occurs has heretofore not been demonstrated.

12 May 2008

Adult human stem cells shown not to pose a cancer risk when implanted into different organs

A new study by UC Davis researchers provides evidence that methods using human bone marrow-derived stem cells to deliver gene therapy to cure diseases of the blood, bone marrow and certain types of cancer do not cause the development of tumors or leukemia.

6 May 2008

Geron Corporation awarded UK grant funding for human embryonic stem cell research

Geron Corporation announced today two grant awards to the University of Edinburgh from the UK Stem Cell Foundation, with funding from the Medical Research Council and Scottish Enterprise.